Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
BHP Shares Fall as Jansen Potash Project Costs Surge 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
SK Hynix Overtakes Samsung as South Korea’s Most Valuable Company 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Trump Says Anthropic No Longer Seen as National Security Threat 
Warren Buffett's Berkshire Hathaway (NYSE:BRKa) disclosed its 13F filing for Q4 2024, revealing a notable investment in Constellation Brands (NYSE:STZ). The firm acquired 5.62 million Constellation shares, valued at $1.24 billion. Following the announcement, Constellation Brands stock surged 6% in after-hours trading, despite a 25.8% year-to-date decline.
Berkshire trimmed its stakes in major financial institutions. The company reduced its Citigroup (NYSE:C) holdings by 74%, lowering its position to 14.6 million shares. It also cut its Bank of America (NYSE:BAC) stake—formerly its second-largest holding—by 15%, bringing shares down to 680.2 million.
The report highlighted that Berkshire paused its Apple Inc (NASDAQ:AAPL) sell-off, maintaining 300 million shares, unchanged from Q3. This holding remains significantly lower than the 790 million shares owned at the end of 2023.
Additionally, Berkshire reduced its stake in DaVita HealthCare (NYSE:DVA) by approximately $32 million.
Investors closely monitor Berkshire's 13F filings, as Warren Buffett's long-term investment strategy influences market trends. Despite being 45 days old, the data offers insights into Berkshire's evolving portfolio and market outlook.
